NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/21/2020
Back to search
Official data from USPTO
XYLOCAINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/21/2020
Trademark type
Word
Nice classes
5, 18
Filing date
05/29/1958
Registration date
02/09/1960
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2020
Last transaction
03/21/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/31/1948
First use in commerce
12/31/1948
Drawing code
1
Owner type
16
Owner location
Lake Zurich, IL
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
FRESENIUS KABI USA, LLC
APP Pharmaceuticals, LLC
ABRAXIS BIOSCIENCE, INC.
A. L. (pessoa física)
ASTRA PHARMACEUTICALS, LP
ASTRA PHARMACEUTICAL PRODUCTS, INC.
Representatives
Lynn A. Sullivan Leydig Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 5Class 18
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 18
ANESTHETIC USED IN MEDICINESURGERYDENTISTRY TO INDUCE LOCAL ANESTHESIAINCLUDING TOPICAL ANESTHESIAWHICH MAY BE PREPARED IN DIFFERENT FORMS-NAMELYAS SOLUTIONS FOR INJECTIONINFUSIONSPRAY; AS AN OINTMENT; AS A JELLY; IN A VISCOUS FORM FOR ORAL USE; AS A TABLETAS A SUPPOSITORY; ALSO USED AS AN ANESTHETIC INGREDIENT IN PHARMACEUTICAL PREPARATIONS
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL4
REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)
03/21/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/21/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
01/27/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/09/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/25/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/13/2012
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
01/23/2010
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/23/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/20/2010
E89R
TEAS SECTION 8 & 9 RECEIVED
11/30/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/30/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/30/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/11/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/22/2008
CFIT
CASE FILE IN TICRS
10/22/2008
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/19/2007
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/21/2007
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/16/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/10/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/10/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/17/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/17/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/09/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/09/2007
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/09/2006
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/15/2000
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/15/2000
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
01/19/2000
REN1
REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)
02/09/1980
Continuous trademark protection
Get notified about every new filing that threatens XYLOCAINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.